Centro de Investigaciones Endocrinológicas "Dr César Bergadá" (CEDIE), CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, C1425EFD Buenos Aires, Argentina.
Sorbonne Universitté, INSERM, Centre de Recherche Saint Antoine (CRSA), IHU ICAN, 75012 Paris, France.
Biol Reprod. 2018 Dec 1;99(6):1303-1312. doi: 10.1093/biolre/ioy152.
Testicular anti-Müllerian hormone (AMH) production is inhibited by androgens around pubertal onset, as observed under normal physiological conditions and in patients with precocious puberty. In agreement, AMH downregulation is absent in patients with androgen insensitivity. The molecular mechanisms underlying the negative regulation of AMH by androgens remain unknown. Our aim was to elucidate the mechanisms through which androgens downregulate AMH expression in the testis. A direct negative effect of androgens on the transcriptional activity of the AMH promoter was found using luciferase reporter assays in the mouse prepubertal Sertoli cell line SMAT1. A strong inhibition of AMH promoter activity was seen in the presence of both testosterone and DHT and of the androgen receptor. By site-directed mutagenesis and chromatin immunoprecipitation assays, we showed that androgen-mediated inhibition involved the binding sites for steroidogenic factor 1 (SF1) present in the proximal promoter of the AMH gene. In this study, we describe for the first time the mechanism behind AMH inhibition by androgens, as seen in physiological and pathological conditions in males. Inhibition of AMH promoter activity by androgens could be due to protein-protein interactions between the ligand-bound androgen receptor and SF1 or by blockage of SF1 binding to its sites on the AMH promoter.
睾丸抗缪勒管激素(AMH)的产生在青春期前受到雄激素的抑制,这在正常生理条件下和性早熟患者中都有观察到。同样,在雄激素不敏感的患者中,AMH 的下调不存在。雄激素负调控 AMH 的分子机制尚不清楚。我们的目的是阐明雄激素下调睾丸中 AMH 表达的机制。通过在小鼠未成熟 Sertoli 细胞系 SMAT1 中进行荧光素酶报告基因检测,发现雄激素对 AMH 启动子的转录活性有直接的负向影响。在存在睾酮和 DHT 以及雄激素受体的情况下,AMH 启动子活性受到强烈抑制。通过定点突变和染色质免疫沉淀检测,我们表明雄激素介导的抑制涉及 AMH 基因近端启动子中存在的类固醇生成因子 1(SF1)结合位点。在这项研究中,我们首次描述了男性生理和病理条件下雄激素抑制 AMH 的机制。雄激素对 AMH 启动子活性的抑制可能是由于配体结合的雄激素受体和 SF1 之间的蛋白-蛋白相互作用,或者是由于 SF1 结合其在 AMH 启动子上的位点被阻断。